What is Joshua Hoffman's approval rating as Zymergen's CEO?

64 employees have rated Zymergen Chief Executive Officer Joshua Hoffman on Glassdoor.com . Joshua Hoffman has an approval rating of 62% among the company's employees. This puts Joshua Hoffman in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 58.0% of employees surveyed would recommend working at Zymergen to a friend.

When did Zymergen IPO?

Zymergen (ZY) raised $401 million in an initial public offering on Thursday, April 22nd 2021. The company issued 13,600,000 shares at $28.00-$31.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen, UBS Investment Bank and Lazard served as the underwriters for the IPO.

NASDAQ:ZY

Zymergen (ZY) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free ZY Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $2.43
▼
$2.43
50-Day Range: $2.35
▼
$3.14
52-Week Range: $1.10
▼
$12.42

Volume: 85 shs
Average Volume: 1.23 million shs
Market Capitalization: $253.58 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Zymergen alerts:

Ad Manward Press

Can't believe it's happening again

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

About Zymergen Stock (NASDAQ:ZY)

Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.

Ad Manward Press

Can't believe it's happening again

We explain how this event works in full right here.

ZY Stock News Headlines

April 10, 2024 | finance.yahoo.com

Method Communications Introduces New Leadership Structure to Accelerate Momentum

March 21, 2024 | tmcnet.com

Molecular Robotics Market Share Analysis, Industry Trends & Statistics and 10 Year Growth Forecasts 2019-2029

April 16, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 13, 2024 | msn.com

GM Appoints Former Tesla and Google Executive to Succeed Retiring Head of Manufacturing

March 13, 2024 | marketwatch.com

GM Taps Former Tesla Gigafactory Head To Lead Manufacturing

March 1, 2024 | finance.yahoo.com

Q4 2023 Ginkgo Bioworks Holdings Inc Earnings Call

February 13, 2024 | finance.yahoo.com

MATTERWORKS ANNOUNCES BOARD UPDATES

January 19, 2024 | bizjournals.com

SmartLabs gets $48M investment; CEO says 'we’re not done'

April 16, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

January 11, 2024 | finance.yahoo.com

SmartLabs Announces Biopharma Veteran Brian Taylor as New Interim CEO

November 8, 2023 | finance.yahoo.com

Ginkgo Bioworks Holdings Inc (DNA) Reports Q3 2023 Financial Results

November 8, 2023 | msn.com

Tech and biotech firms slash hundreds of Bay Area jobs as layoffs widen

November 7, 2023 | msn.com

Ginkgo Bioworks Holdings Q3 2023 Earnings Preview

October 24, 2023 | msn.com

Gingko Bioworks, Penn State partner on wildlife biothreat research

October 4, 2023 | msn.com

Ginkgo Bioworks and Zymergen: A tale of two IPOs ends in bankruptcy

October 4, 2023 | markets.businessinsider.com

Analyst Cautions on Ginkgo Bioworks’ Financial Prospects Despite Promising Collaborations and Sector Position

September 27, 2023 | benzinga.com

Accelerator Life Science Partners Launches Biotechnology Startup Company in Singapore with $16M in Series A Commitments

September 19, 2023 | finance.yahoo.com

Tarsadia Strengthens Venture, Growth & Private Investing Practice with New Sector Heads

September 14, 2023 | sg.news.yahoo.com

Al Gore and Lila Preston ask the tough questions in their firm's new climate report

September 13, 2023 | ca.style.yahoo.com

Al Gore and Lila Preston question everything in their firm's new climate report

September 13, 2023 | techcrunch.com

Al Gore and Lila Preston ask the tough questions in their firm’s new climate report

August 22, 2023 | finance.yahoo.com

MycoWorks Welcomes Three Executives to Leadership Team

August 22, 2023 | venturebeat.com

Cascade Biocatalysts Secures $2.6 M to Scale Enzymes for Biomanufacturing

May 23, 2023 | bizjournals.com

Life sciences incubator in Vacaville looks to attract, retain hub's biotechs

May 17, 2023 | marketwatch.com

Nano Robots Market Reports, Scope, Methodology, Timelines And Challenges Forecast Till 2030

May 16, 2023 | technews.tmcnet.com

Prescient Appoints Three New Members to its Board of Directors

May 4, 2023 | marketwatch.com

Nano Robots Market Global Trends, Segmentation and Opportunities Forecast To 2030

See More Headlines

Receive ZY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zymergen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Basic Materials
Industry: Commercial physical research
Sub-Industry: N/A
Current Symbol: NASDAQ:ZY
CUSIP: N/A
CIK: 1645842
Web: www.zymergen.com
Phone: 415-801-8073
Fax: N/A
Employees: 502
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($3.55)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-361,790,000.00
Net Margins: -2,508.94%
Pretax Margin: -2,508.42%
Return on Equity: -93.37%
Return on Assets: -61.14%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.59
Quick Ratio: 4.47

Sales & Book Value

Annual Sales: $16.74 million
Price / Sales: 15.15
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.99 per share
Price / Book: 0.61

Miscellaneous

Outstanding Shares: 104,355,000
Free Float: 92,145,000
Market Cap: $253.58 million
Optionable: Not Optionable
Beta: 1.69

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Ms. Enakshi Singh (Age 44)
Chief Financial Officer
Comp: $390.3k
Mr. Dmitriy Ryaboy
Chief Technology Officer
Mike Dulin
Director of Communications
Mr. Lincoln Germain
Chief Commercial Officer
Mr. Subodh S. Deshmukh
Chief Devel. Officer
Mr. Devin Scannell
Sr. VP of Drug Discovery
Mr. Duane Valz J.D.
Sec.
Ms. Mina Kim (Age 48)
Corp. Sec.

Key Competitors

View All Competitors

ZY Stock Analysis - Frequently Asked Questions

What is Joshua Hoffman's approval rating as Zymergen's CEO?: 64 employees have rated Zymergen Chief Executive Officer Joshua Hoffman on Glassdoor.com. Joshua Hoffman has an approval rating of 62% among the company's employees. This puts Joshua Hoffman in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 58.0% of employees surveyed would recommend working at Zymergen to a friend.
When did Zymergen IPO?: Zymergen (ZY) raised $401 million in an initial public offering on Thursday, April 22nd 2021. The company issued 13,600,000 shares at $28.00-$31.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen, UBS Investment Bank and Lazard served as the underwriters for the IPO.

This page (NASDAQ:ZY) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Zymergen (ZY) Stock Price, News & Analysis

About Zymergen Stock (NASDAQ:ZY)

ZY Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ZY Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info